Effective communication is essential for patient engagement and retention during a clinical trial – especially as more trials are moving to virtual or decentralised models.

The #NoGoingBack pledge is a statement from organisations across the world to continue forging forward. It’s a united front, and shows the importance of clinical leaders coming together to continue the momentum we’ve created in improving clinical trial conduct around the world.

Patient influence in clinical trials is extending, from understanding patients’ needs and engaging them in the clinical development process, to giving patients the freedom to choose what’s right for them. In a recent virtual conference presentation, our VP, Patient Engagement, Vale Nicoli-Carr, talked about how we need to take our understanding of patients’ needs and put patients in the driving seat in clinical trials.

Our webinar panel discussed the challenges with new clinical trial technologies and how to deploy technologies that can deliver greater patient insight and engagement to ultimately improve patients’ safety and their trial experience.

The clinical trial landscape has changed dramatically since the outbreak of COVID-19. For the clinical research industry, these past few months have been anything but business as usual. However, it hasn’t meant clinical trials can’t continue, and many in the industry have been working together to find a ‘new normal’.

Let’s take a look at some of the ways in which wearable sensors have changed the landscape of healthcare and clinical research.